Blog Large Image

New summer menus available from 12th Sept.

A $10.6 million, five-year EPA contract for Stemina Biomarker Discovery, announced this week, doesn’t just provide a new source of revenue. It also holds the potential to make the Madison company’s technology a standard for testing chemicals and drugs for their toxic effects, long-term, CEO...

Cary, NC - November 17, 2013. BMG LABTECH, Inc. - the Microplate Reader Company - and InvivoSciences, Inc. - a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery - announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader technologies. Employing an automated system, 3D heart tissues are fabricated with cardiomyocytes derived from human induced pluripotent stem cells. The ultra- sensitive plate reader, CLARIOstar®, will analyze rapid beat-to-beat changes (up to 50 Hz) in the fluorescence intensities of dyes that indicate physiological states in engineered 3D heart tissue after drug/compound application.

In 2008, before tech accelerator programs exploded onto the scene, a couple of successful Madison entrepreneurs had a smaller idea: To form a group that would give one-on-one help to people with a promising concept but little knowledge how to turn it into a real business. With backing from UW-Madison, Terry Sivesind and Toni Sikes created MERLIN (Madison Entrepreneur Resource, Learning and Innovation Network) Mentors.

Business incubators--more than 300 in the U.S., many attached to universities--are increasingly drawing intellectual capital from around the world. With the help of CB Insights, a Manhattan firm that tracks private-company funding trends, University Research Park and the MG&E Innovation Center were cited by Forbes...

Last Friday was Mark Bugher's final day on the job as director of University Research Park. He has headed it since leaving Governor Tommy Thompson's administration, for which he served as secretary of the Department of Administration.

After Tony Kolton sold his software company -- Logical Information Machines – in 2009, he sailed in the Caribbean and enjoyed other recreational pursuits. But it didn’t take the 59-year-old Kolton long to grow bored. With an interest in biotechnology, he turned his attention to the potential of stem cell therapies and founded Regenerative Medical Solutions in January of 2012. The startup, based at University Research Park in Madison, is working to help cure diabetes.